Covered recipient · General Payments record
SRIJAYA BANDI
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$2,712.85
- Reported across 159 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $407.26 | 25 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $189.40 | 12 |
| Novo Nordisk AS | $46.95 | 2 |
| Abbott Laboratories | $33.51 | 2 |
| ABBVIE INC. | $31.55 | 2 |
| Acerta Pharma LLC | $30.41 | 2 |
| Astellas Pharma US Inc | $29.84 | 2 |
| Amgen Inc. | $27.38 | 2 |
| GlaxoSmithKline, LLC. | $18.22 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (25)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $18.33 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124968857 | CMS |
| Abbott Laboratories | $15.18 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124968861 | CMS |
| ABBVIE INC. | $16.23 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103274291 | CMS |
| ABBVIE INC. | $15.32 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103274293 | CMS |
| Amgen Inc. | $13.46 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117500928 | CMS |
| Amgen Inc. | $13.92 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117500930 | CMS |
| Astellas Pharma US Inc | $14.76 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139317438 | CMS |
| Astellas Pharma US Inc | $15.08 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139359149 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.21 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104563172 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.20 | 12/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105835193 | CMS |
| GlaxoSmithKline, LLC. | $18.22 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116466140 | CMS |
| Lilly USA, LLC | $9.12 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135430257 | CMS |
| Lilly USA, LLC | $8.15 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135349483 | CMS |
| Lilly USA, LLC | $19.78 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135430259 | CMS |
| Lilly USA, LLC | $22.48 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135413749 | CMS |
| Lilly USA, LLC | $18.47 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135398237 | CMS |
| Lilly USA, LLC | $8.95 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135349485 | CMS |
| Lilly USA, LLC | $23.22 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135428993 | CMS |
| Lilly USA, LLC | $15.97 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135410615 | CMS |
| Lilly USA, LLC | $10.75 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135398239 | CMS |
| Lilly USA, LLC | $21.45 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135428995 | CMS |
| Lilly USA, LLC | $11.52 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135410617 | CMS |
| Lilly USA, LLC | $19.54 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135398241 | CMS |
| Novo Nordisk Inc | $23.20 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096814155 | CMS |
| Novo Nordisk Inc | $23.75 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097746444 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.